Development  	Development  	 NN	O
of  	of  	 IN	O
a  	a  	 DT	O
plasma-  	plasma-  	 JJ	B-NP
and  	and  	 CC	O
albumin-free  	albumin-free  	 JJ	B-NP
recombinant  	recombinant  	 JJ	O
von  	von  	 NNP	O
Willebrand  	Willebrand  	 NNP	O
factor  	factor  	 NN	O
Baxter  	Baxter  	 NNP	O
has  	has  	 VBZ	O
developed  	developed  	 VBN	O
a  	a  	 DT	O
recombinant  	recombinant  	 JJ	O
therapy  	therapy  	 NN	O
for  	for  	 IN	O
treating  	treating  	 VBG	B-NP
von  	von  	 NNP	I-NP
Willebrand 	Willebrand 	 NNP	I-NP
's  	's  	 POS	I-NP
disease 	disease 	 NN	O
.  	.  	 .	O
Recombinant  	Recombinant  	 NNP	O
VWF  	VWF  	 NNP	B-NP
is  	is  	 VBZ	O
co-expressed  	co-expressed  	 JJ	O
with  	with  	 IN	O
the  	the  	 DT	O
rFVIII  	rFVIII  	 JJ	O
in  	in  	 IN	O
CHO  	CHO  	 NNP	B-NP
cells  	cells  	 NNS	O
used  	used  	 VBN	O
to  	to  	 TO	O
produce  	produce  	 VB	O
the  	the  	 DT	O
rFVIII  	rFVIII  	 JJ	B-NP
product  	product  	 NN	I-NP
Advate 	Advate 	 NNP	I-NP
.  	.  	 .	O
This  	This  	 DT	O
rVWF  	rVWF  	 NN	B-NP
is  	is  	 VBZ	O
used  	used  	 VBN	O
as  	as  	 IN	O
a  	a  	 DT	O
drug  	drug  	 NN	B-NP
component  	component  	 NN	I-NP
for  	for  	 IN	I-NP
a  	a  	 DT	I-NP
rVWF-rFVIII  	rVWF-rFVIII  	 JJ	I-NP
complex  	complex  	 JJ	O
drug  	drug  	 NN	B-NP
product 	product 	 NN	I-NP
.  	.  	 .	O
CHO  	CHO  	 NNP	B-NP
cells  	cells  	 NNS	O
produce  	produce  	 VBP	O
partially  	partially  	 RB	O
processed  	processed  	 VBN	O
and  	and  	 CC	O
partially  	partially  	 RB	O
un-processed  	un-processed  	 JJ	B-NP
rVWF  	rVWF  	 NN	I-NP
still  	still  	 RB	O
containing  	containing  	 VBG	O
the  	the  	 DT	O
pro-peptide 	pro-peptide 	 JJ	B-NP
.  	.  	 .	O
In  	In  	 IN	O
order  	order  	 NN	O
to  	to  	 TO	O
make  	make  	 VB	O
a  	a  	 DT	O
consistent  	consistent  	 JJ	O
preparation  	preparation  	 NN	B-NP
containing  	containing  	 VBG	O
mature  	mature  	 JJ	O
and  	and  	 CC	O
processed  	processed  	 VBN	O
rVWF  	rVWF  	 JJ	B-NP
only  	only  	 JJ	I-NP
rVWF  	rVWF  	 NN	I-NP
is  	is  	 VBZ	O
exposed  	exposed  	 VBN	O
to  	to  	 TO	O
recombinant  	recombinant  	 VB	O
furin  	furin  	 VBN	O
to  	to  	 TO	O
remove  	remove  	 VB	O
the  	the  	 DT	O
pro-peptide 	pro-peptide 	 JJ	B-NP
.  	.  	 .	O
Recombinant  	Recombinant  	 NNP	O
VWF  	VWF  	 NNP	B-NP
and  	and  	 CC	O
furin  	furin  	 NNS	B-NP
are  	are  	 VBP	O
produced  	produced  	 VBN	O
under  	under  	 IN	O
serum-  	serum-  	 JJ	B-NP
and  	and  	 CC	O
protein-free  	protein-free  	 JJ	B-NP
conditions 	conditions 	 NNS	I-NP
.  	.  	 .	O
It  	It  	 PRP	O
is  	is  	 VBZ	O
highly  	highly  	 RB	O
purified  	purified  	 VBN	O
by  	by  	 IN	O
a  	a  	 DT	O
series  	series  	 NN	O
of  	of  	 IN	O
chromatographic  	chromatographic  	 JJ	B-NP
steps  	steps  	 NNS	I-NP
and  	and  	 CC	O
formulated  	formulated  	 VBN	O
in  	in  	 IN	O
a  	a  	 DT	O
protein-free  	protein-free  	 JJ	B-NP
buffer  	buffer  	 NN	I-NP
and  	and  	 CC	O
has  	has  	 VBZ	O
a  	a  	 DT	O
homogeneous  	homogeneous  	 JJ	B-NP
multimer  	multimer  	 JJ	I-NP
distribution 	distribution 	 NN	I-NP
.  	.  	 .	O
The  	The  	 DT	O
specific  	specific  	 JJ	O
activity  	activity  	 NN	O
is  	is  	 VBZ	O
higher  	higher  	 JJR	O
in  	in  	 IN	O
rVWF  	rVWF  	 JJ	O
than  	than  	 IN	O
in  	in  	 IN	O
commercial  	commercial  	 JJ	B-NP
plasma-derived  	plasma-derived  	 JJ	I-NP
VWF-FVIII  	VWF-FVIII  	 JJ	I-NP
complex  	complex  	 JJ	O
products 	products 	 NNS	O
.  	.  	 .	O
SDS  	SDS  	 NNP	B-NP
agarose  	agarose  	 VBD	O
electrophoretic  	electrophoretic  	 JJ	B-NP
analysis  	analysis  	 NN	I-NP
shows  	shows  	 VBZ	O
the  	the  	 DT	O
presence  	presence  	 NN	O
of  	of  	 IN	O
ultra-high  	ultra-high  	 JJ	B-NP
molecular  	molecular  	 JJ	I-NP
weight  	weight  	 NN	I-NP
multimers 	multimers 	 NN	I-NP
.  	.  	 .	O
The  	The  	 DT	O
FVIII-binding  	FVIII-binding  	 JJ	B-NP
capacity  	capacity  	 NN	I-NP
and  	and  	 CC	O
affinity  	affinity  	 NN	B-NP
of  	of  	 IN	O
rVWF  	rVWF  	 JJ	O
to  	to  	 TO	O
FVIII  	FVIII  	 NNP	B-NP
is  	is  	 VBZ	O
comparable  	comparable  	 JJ	O
to  	to  	 TO	O
VWF  	VWF  	 NNP	B-NP
in  	in  	 IN	O
plasma 	plasma 	 NN	B-NP
.  	.  	 .	O
Carbohydrate  	Carbohydrate  	 JJ	B-NP
analysis  	analysis  	 NN	I-NP
shows  	shows  	 VBZ	O
an  	an  	 DT	O
intact  	intact  	 JJ	O
glycosylation  	glycosylation  	 JJ	B-NP
pattern 	pattern 	 NN	I-NP
.  	.  	 .	O
Recombinant  	Recombinant  	 NNP	O
VWF  	VWF  	 NNP	B-NP
binds  	binds  	 VBD	O
to  	to  	 TO	O
collagen  	collagen  	 VB	O
and  	and  	 CC	O
promotes  	promotes  	 VBZ	O
platelet  	platelet  	 JJ	B-NP
adhesion  	adhesion  	 NN	I-NP
under  	under  	 IN	O
shear  	shear  	 JJ	O
stress 	stress 	 NN	O
.  	.  	 .	O
It  	It  	 PRP	O
stabilizes  	stabilizes  	 VBZ	O
endogenous  	endogenous  	 JJ	B-NP
FVIII  	FVIII  	 NN	I-NP
in  	in  	 IN	O
VWF-deficient  	VWF-deficient  	 JJ	B-NP
knock-out  	knock-out  	 JJ	O
mice  	mice  	 NNS	O
as  	as  	 RB	O
seen  	seen  	 VBN	O
by  	by  	 IN	O
a  	a  	 DT	O
secondary  	secondary  	 JJ	B-NP
rise  	rise  	 NN	I-NP
in  	in  	 IN	O
murine  	murine  	 JJ	B-NP
FVIII 	FVIII 	 NNP	I-NP
.  	.  	 .	O
